Table A1: GRADE Evidence Profile for Advanced Access in a Diabetes Population.
No. of Studies (Design) | Risk of Bias | Inconsistency | Indirectness | Imprecision | Publication Bias | Upgrade Considerations | Quality |
---|---|---|---|---|---|---|---|
Hospitalization | |||||||
2 (observational, 1 with concurrent controls) | No serious limitations | No serious limitations | No serious limitations | No serious limitations | Undetected | None | ⊕⊕ Low |
Emergency Department/Urgent Care Visits | |||||||
2 (observational, 1 with concurrent controls) | No serious limitations | Serious limitations (-1) | No serious limitations | No serious limitations | Undetected | None | ⊕ Very Low |
Length of Stay | |||||||
1 (observational) | Serious limitations (-1)a | NA | No serious limitations | No serious limitations | Undetected | None | ⊕ Very Low |
HbA1c | |||||||
3 (observational, 1 with concurrent controls) | No serious limitations | Serious limitations (-1) | No serious limitations | No serious limitations | Undetected | None | ⊕ Very Low |
LDL-C | |||||||
3 (observational, 1 with concurrent controls) | No serious limitations | Serious limitations (-1) | No serious limitations | No serious limitations | Undetected | None | ⊕ Very Low |
Blood Pressure | |||||||
2 (observational, 1 with concurrent controls) | No serious limitations | Serious limitations (-1) | No serious limitations | No serious limitations | Undetected | None | ⊕ Very Low |
Abbreviations: HbA1c, hemoglobin A1c; LDL-C, low-density lipoprotein cholesterol; NA, not applicable.
Measure used (percent of patients admitted for greater than 3 days) was not explained and may not be valid.